Barely Significant
← all excerpts

Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury.

Front Immunol · 2019 · PMC6902041 · PMID 31849925

1
hedged sentence
closest p
boldest claim

The sentences

an overall trendno p-value reported
We observed an overall trend toward reduction of ipsilateral brain tissue volume loss of 13–66% across all 6 forebrain regions in the LPS-treated global properdin deletion group ( Figure 2H ) compared to LPS-treated wild type controls ( Figure 2G ) (main effect, p < 0.05, Kruskal-Wallis test), however the data reached significant values only in cortex and pyriform cortex (Bonferroni correction, p < 0.05).

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.